Takeda Pharma ADR Earnings, Revenue beat In Q2
Investing.com - Takeda Pharma ADR reported second quarter {{erl-942220||earnings that beat analysts' expectations on Friday and revenue that topped forecasts. The firm reported earnings...
Neutral
or
Takeda Pharma ADR News & Analysis
-
-
Cathie Wood’s ARK Invest Sells Over 350,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold over 350,000 shares of Takeda Pharmaceutical on June 16.
-
Cathie Wood’s ARK Invest Sells Over 225,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold over 225,000 shares of Takeda Pharma on June 15.
-
Takeda Pharma ADR Earnings, Revenue miss In Q1
Investing.com - Takeda Pharma ADR reported first quarter {{erl-942220||earnings that missed analysts' expectations on Tuesday and revenue that fell short of forecasts. The firm reported...
-
Takeda Pharmaceutical Co Ltd (TAK): Price Now Near $16.86; Daily Chart Shows Downtrend on 20 Day Basis
This move is a reversal from the day prior, which saw price move down. The post Takeda Pharmaceutical Co Ltd (TAK): Price Now Near $16.86; Daily Chart Shows Downtrend on 20 Day Basis...
-
Takeda Pharmaceutical Co Ltd (TAK): Price Now Near $18.75; Daily Chart Shows An Uptrend on 50 Day Basis
If you're a trend trader, consider that the strongest clear trend on the daily chart exists on the 50 day timeframe. The post Takeda Pharmaceutical Co Ltd (TAK): Price Now Near $18.75; Daily...
-
Takeda Pharma ADR Earnings beat, Revenue misses In Q4
Investing.com - Takeda Pharma ADR reported fourth quarter {{erl-942220||earnings that beat analysts' expectations on Thursday and revenue that fell short of forecasts. The firm reported...
-
Takeda Pharma ADR Earnings, Revenue miss In Q3
Investing.com - Takeda Pharma ADR reported third quarter {{erl-942220||earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts. The firm reported...
-
Takeda Pharma ADR Earnings, Revenue beat In Q2
Investing.com - Takeda Pharma ADR reported second quarter {{erl-942220||earnings that beat analysts' expectations on Friday and revenue that topped forecasts. The firm reported earnings...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
